Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
LONDON--(BUSINESS WIRE)---- $IBB #AVLSOM3--AV Laboratories, a science-led skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced it will e
Biotech Investors Are Tuning Out the MAHA Chaos
05:30am, Wednesday, 20'th May 2026
The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why
03:08pm, Friday, 01'st May 2026
Locking in profits while you have them can help avoid downturns.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Tuesday, 28'th Apr 2026
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
01:22pm, Thursday, 23'rd Apr 2026
Biotech has reasserted itself over the past year as drug approvals,
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know
03:26pm, Tuesday, 21'st Apr 2026
Viridian Therapeutics is a clinical-stage biotech awaiting an FDA decision on its lead thyroid eye disease therapy.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:20am, Tuesday, 21'st Apr 2026
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund laun
iShares Biotechnology ETF $IBB Shares Bought by Assetmark Inc.
03:31am, Friday, 17'th Apr 2026
Assetmark Inc. grew its holdings in shares of iShares Biotechnology ETF (NASDAQ: IBB) by 150,979.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securi
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026
10:20am, Tuesday, 07'th Apr 2026
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded.
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead
10:50am, Tuesday, 31'st Mar 2026
The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%. However, the bi
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead
03:50pm, Saturday, 28'th Mar 2026
The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%.
Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win
03:56pm, Tuesday, 24'th Mar 2026
Focused on therapies for rare skin diseases, this clinical-stage biotech saw a notable director purchase coincide with a decisive Phase 3 trial announcement and the closing of a $230 million equity of
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
05:38pm, Saturday, 21'st Mar 2026
DAFNA Capital Management LLC sold 34,405 shares of iShares Biotechnology ETF (IBB) Quarter-end position value decreased by $3.31 million, reflecting both trading and stock price effects Trade represen
Bank of America Corp DE Lowers Holdings in iShares Biotechnology ETF $IBB
03:38am, Tuesday, 17'th Mar 2026
Bank of America Corp DE lowered its position in iShares Biotechnology ETF (NASDAQ: IBB) by 4.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities
